Pets

According to google ~

AIM (Apoptosis Inhibitor of Macrophage) therapy is a groundbreaking treatment for feline chronic kidney disease (CKD) aimed at restoring the kidney's waste-clearing mechanism, potentially reversing or stopping disease progression. Developed by Dr. Toru Miyazaki, this approach uses injections or supplements to activate dormant AIM protein, allowing it to clear debris that causes kidney failure.Key Details on AIM TreatmentHow it Works: Cats often cannot activate their own AIM protein, which leads to waste buildup. The treatment introduces functioning AIM to remove this debris, essentially unclogging the kidneys.Treatment Forms: Research includes both injected therapeutic drugs (designed to act directly) and oral supplements (designed to activate natural AIM in the blood).Effectiveness: Studies show promise in extending survival, with one study showing a 360-day survival rate of roughly 80% in treated cats versus 20% in untreated controls.Availability: While not yet widely available in a clinical setting, AIM-based treatments are in late-stage development. Some products based on this research have already been used by thousands of cats, particularly in Japan and Korea, with high user satisfaction.Future Impact: The treatment aims to turn fatal kidney disease into a manageable condition, potentially doubling the lifespan of affected cats.While the full therapeutic drug is expected to enter further clinical trials, current dietary, and nutritional management aimed at reducing the burden on the kidneys is standard care until this therapy is widely available.

Link to Japanese company seeking approval for treatment ~
https://www.japantimes.co.jp/news/2026/04/27/japan/science-health/cat-kidney-disease-treatment/